In brief: Regenera, Compumedics, SciGen
Friday, 21 October, 2005
Regenera (ASX:RGA) has appointed Hon Dr Michael Woodridge as non-executive chairman effective immediately, subject to shareholder approval. Woodridge is a former federal minister for health and is currently chairman of Neurosciences Australia, the Cooperative Research Centre in Oral Health Science, Resonance Health (ASX:RHT), Dia-B (ASX:DIA) and a board member of Cogstate (ASX:CGS), Research Australia and the Centre for Eye Research Australia.
Koichiro Koike has resigned as a director of Compumedics (ASX:CMP) due to health reasons. The company has yet to decide on a replacement and when that will occur.
Dr Colin Goldschmidt and Chris Wilks will today step down as directors of SciGen (ASX:SIE) due to their time commitments to Sonic Healthcare, a company which spun out of SciGen in 2002.
Cartherics and Catalent announce enhanced partnership
To support immune cell therapy products for the treatment of cancer and endometriosis, Australian...
Alliance seeks to boost regional capacity in clinical trials
Launched this week, the Barwon Health–Deakin University Clinical Trials Alliance is...
Lipid science receives new Australia-led online hub
The Lipid Network launched this month to build links between researchers, clinicians and industry...
